These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 16301010)

  • 21. [Efficacy of infliximab in treatment of pediatric Crohn's disease in China].
    Luo Y; Yu J; Zhao H; Peng K; Lou J; Ma M; Chen J
    Zhonghua Er Ke Za Zhi; 2014 Sep; 52(9):688-92. PubMed ID: 25476432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of nutritional therapy for active Crohn's disease.
    Fukuda Y; Kosaka T; Okui M; Hirakawa H; Shimoyama T
    J Gastroenterol; 1995 Nov; 30 Suppl 8():83-7. PubMed ID: 8563899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial.
    Verma S; Brown S; Kirkwood B; Giaffer MH
    Am J Gastroenterol; 2000 Mar; 95(3):735-9. PubMed ID: 10710067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crohn's disease: current treatment options.
    Akobeng AK
    Arch Dis Child; 2008 Sep; 93(9):787-92. PubMed ID: 18456695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic efficacy of infliximab on active Crohn's disease under nutritional therapy.
    Matsumoto T; Iida M; Kohgo Y; Imamura A; Kusugami K; Nakano H; Fujiyama Y; Matsu T; Hibi T
    Scand J Gastroenterol; 2005 Dec; 40(12):1423-30. PubMed ID: 16316890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous elemental enteral alimentation in children with Crohn's disease and growth failure.
    Morin CL; Roulet M; Roy CC; Weber A
    Gastroenterology; 1980 Dec; 79(6):1205-10. PubMed ID: 6777234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease.
    Swaminath A; Feathers A; Ananthakrishnan AN; Falzon L; Li Ferry S
    Aliment Pharmacol Ther; 2017 Oct; 46(7):645-656. PubMed ID: 28815649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indications and options of nutritional treatment for Crohn's disease. A comparison of elemental and polymeric diets.
    Matsui T; Ueki M; Yamada M; Sakurai T; Yao T
    J Gastroenterol; 1995 Nov; 30 Suppl 8():95-7. PubMed ID: 8563903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors affecting recurrence in patients with Crohn's disease under nutritional therapy.
    Esaki M; Matsumoto T; Nakamura S; Yada S; Fujisawa K; Jo Y; Iida M
    Dis Colon Rectum; 2006 Oct; 49(10 Suppl):S68-74. PubMed ID: 17106818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
    Targan SR; Feagan BG; Fedorak RN; Lashner BA; Panaccione R; Present DH; Spehlmann ME; Rutgeerts PJ; Tulassay Z; Volfova M; Wolf DC; Hernandez C; Bornstein J; Sandborn WJ;
    Gastroenterology; 2007 May; 132(5):1672-83. PubMed ID: 17484865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study.
    Valentine JF; Fedorak RN; Feagan B; Fredlund P; Schmitt R; Ni P; Humphries TJ
    Gut; 2009 Oct; 58(10):1354-62. PubMed ID: 19505878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn's disease.
    Israel DM; Hassall E
    Am J Gastroenterol; 1995 Jul; 90(7):1084-8. PubMed ID: 7611202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Nutritional treatment in childhood Crohn's disease].
    Comité de nutrition de la Société française de pédiatrie
    Arch Pediatr; 2005 Aug; 12(8):1255-66. PubMed ID: 16051079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Crohn's disease and enteral feeding: comparative nutritional efficacy of elemental and polymeric nutritive mixtures].
    Cosnes J; Bellanger J; Gendre JP; Le Quintrec Y
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):233-40. PubMed ID: 3144938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
    Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
    Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Azathioprine therapy in steroid-dependent patients with Crohn disease: results of a 10-year longitudinal follow-up study.
    Pinto AL; Chebli LA; Ribeiro MS; Pace FH; Moraes JP; do Amaral FJ; Gaburri PD; Meirelles de Souza AF; Chebli JM
    Med Sci Monit; 2009 May; 15(5):PI19-26. PubMed ID: 19396048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
    Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study.
    Yamamoto T; Nakahigashi M; Umegae S; Kitagawa T; Matsumoto K
    Aliment Pharmacol Ther; 2007 Jan; 25(1):67-72. PubMed ID: 17229221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.